Concepedia

Ningning Luo

NL

4

Publications

119

Citations

4

H-Index

2013

Active since

Affiliations

Simcere Pharmaceutical (China)(Current)

Shandong First Medical University

Shandong Tumor Hospital

Ningning Luo is an author at Simcere Pharmaceutical (China) specializing in morphogenesis, cell motility, and signal transduction.

ORCID

Top concepts

Publications per year

2013–2023

4

Publications

4

Arp2/3 complex is essential for actin network treadmilling as well as for targeting of capping protein and cofilin

Stefan A. Koestler, Anika Steffen, Maria Némethová et al. · Molecular Biology of the Cell · 2013 · 78 citations · Full text

, , +18

Clinical efficacy and biomarker analysis of neoadjuvant camrelizumab plus chemotherapy for early-stage triple-negative breast cancer: a experimental single-arm phase II clinical trial pilot study

Chunhui Zheng, Yanbing Liu, Xue’er Wang et al. · International Journal of Surgery · 2023 · 15 citations · Full text

<p>A Novel <em>MYH9-RET</em> Fusion Occurrence and <em>EGFR</em> T790M Loss as an Acquired Resistance Mechanism to Osimertinib in a Patient with Lung Adenocarcinoma: A Case Report</p>

Yanwei Sun, Lina Pei, Ningning Luo et al. · OncoTargets and Therapy · 2020 · 14 citations · Full text

The joint detection of CEA and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer

Yong Wang, Ningning Luo, Ye Gao et al. · Journal of Cancer Research and Clinical Oncology · 2022 · 12 citations · Full text

Rows per page

1–4 of 4